MINNEAPOLIS—Best Buy announced it will begin selling continuous glucose monitors (CGMs) via prescription and deliver them to homes.
Facilitated by Wheel, a virtual care platform, and HealthDyne, a pharmacy technology provider, Best Buy will sell the Dexcom G7 Continuous Glucose Monitoring System to eligible customers through BestBuy.com. They will be taken to the company's new platform, Wellness.BestBuyHealth.com to complete the process. Leveraging the Salesforce platform, Best Buy is selling glucose monitors via a site powered by Commerce Cloud.
"With more CGM system options aimed to come soon after launch, this is the first time we will offer prescription based medical devices to our customers," Best Buy said in a news release.
In the release, the company said it is responding to a growing demand for CGM, as more than 10% of the U.S. population has diabetes, and that it adds to electronics retailer's roster of health-based technology products.
"The expansion also aligns perfectly with the goal of Best Buy Health to enable care at home for everyone by relying on partners to provide care for patients while sticking to what we do best, providing technology and expertise that enriches and saves lives," the release said.
Once available, customers looking for the Dexcom G7 can find it on BestBuy.com, where they will be brought to the new platform by clicking “Get Started,” or can visit Wellness.BestBuyHealth.com to begin the process with Wheel and determine eligibility. If approved, the prescription will then be processed by HealthDyne and the device will be sent to their home.
The eventual goal is to allow patients with an existing CGM prescription from their own physician to be able to upload that prescription into their profile and have the device sent to them. Best Buy will not be able to accept insurance payment for CGM systems at launch, however.
